<DOC>
	<DOCNO>NCT01743885</DOCNO>
	<brief_summary>There effective treatment hemangioma regardless immediate severity . That respect orphan disease . These hemangioma , sometimes large , phase proliferation several month ( scary parent ) regression several year . The natural history pepper local complication ( ulcer ) aesthetic psychological sequela ( sometimes major child family ) . The effect acebutolol propranolol proliferative hemangioma discover accidentally two French team ( Montpellier acebutolol Bordeaux propranolol ) . Acebutolol propranolol use many year treatment hypertension congenital heart disease , include infant , side effect . The effect acebutolol propranolol immediately visible reduced volume skin whiten hemangioma . In preliminary study , acebutolol administer 20 patient Montpellier big regression hemangioma . The aim study compare clinical efficacy acebutolol ( 10mg/Kg/jour ) propranolol ( 3mg/Kg/j ) proliferative phase infantile hemangioma infant .</brief_summary>
	<brief_title>Efficacy Safety Propranolol Versus Acebutolol Proliferative Phase Infantile Hemangioma</brief_title>
	<detailed_description />
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Hemangioma , Capillary</mesh_term>
	<mesh_term>Port-Wine Stain</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Acebutolol</mesh_term>
	<criteria>Infants 6 month Presenting hemangioma follow characteristic : subcutaneous / cutaneous minimum diameter 1.5cm face , 5cm outside face 3cm ulcerated . without functional impairment require treatment vital corticosteroid Consent parent ( person parental authority family ) Which least one parent beneficiary social security system . Indication treatment corticosteroid indication hemangioma Indication treatment betablocker another indication hemangioma Infant presenting consindications administration acebutolol propranolol : Asthma chronic obstructive pulmonary disease severe form . Heart failure control treatment . Cardiogenic shock Prinzmetal Angina Bradycardia ( &lt; 80 beat / min rest first month &lt; 70/minute 1 6 month ) . Raynaud 's phenomenon peripheral arterial disorder severe form . Pheochromocytoma untreated . Low blood pressure ( blood pressure &lt; 60/30 mmHg 6 month ) Hypersensitivity acebutolol propranolol History anaphylactic reaction . Treatment amiodarone / calcium channel blocker . Congenital heart disease outside inter auricular communication ( CIA ) inter ventricular communication ( CIV ) insignificant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hemangioma</keyword>
	<keyword>Beta-blocker</keyword>
	<keyword>Acebutolol</keyword>
	<keyword>Propranolol</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>Infants</keyword>
</DOC>